Scientist Stories: Alfonso Martinez-Arias, On the Self-Engineering of Embryonic Stem Cells

14 Sept 2024 · 35 min
34:44

In this informal yet insightful talk, Alfonso Martinez‑Arias explores the concept of "self‑engineered" biological systems, positioning them between fully engineered devices (e.g., computers) and purely self‑organized phenomena (e.g., clouds). He argues that living tissues, such as the intestinal epithelium, blood, and bone, exemplify self‑engineered systems: they are reproducibly assembled from identical starting cells each time, yet they retain a degree of autonomous organization. The speaker critiques the current organoid field, noting that most organoids (e.g., brain‑like "mini‑brains") are highly variable, whereas intestinal organoids display remarkable reproducibility. He stresses that genetics alone cannot reconstruct these systems and that engineering‑style, quantitative approaches are needed. Historical analogies to Descartes’ mechanistic view of organisms and early automata illustrate the long‑standing desire to build biology. The talk then focuses on gastrulation, the pivotal early developmental event, describing its conserved molecular code and its relevance to disease. Ethical constraints, especially the 14‑day rule governing human embryo research, are discussed, along with the promise of using embryonic stem cells to model early development without embryos. The centerpiece is the development of "gastruloids"—aggregates of mouse (and potentially human) embryonic stem cells that self‑organize an anterior‑posterior axis, express key patterning genes (Brachyury, Hox, Sonic hedgehog), and recapitulate somite and spinal‑cord formation. The speaker emphasizes the importance of precise initial conditions (cell number, volume, timing) for reproducibility, and highlights collaborations with engineers, physicists, and computational biologists to quantify these parameters. He concludes with a call for new, quantitative, engineering‑driven strategies to decode the self‑engineering logic of cells, beyond genetics, to enable reliable disease models and drug testing.

Chapters

More from Joshua

youtube.com

Scientist Stories: Jennifer Doudna, The Code Breaker

10mo ago
youtube.com

Founder Stories: Helmy Eltoukhy, Founder & CEO of Guardant Health

1y ago
youtube.com

Scientist Stories: Fabian Theis, Machine Learning and Systems Biology

2y ago
youtube.com

Scientist Stories: Thomas Lanyon-Hogg, Chemical Biology in Drug Discovery

2y ago
youtube.com

Founder Stories: Bobby Gaspar, Manufacturing Hematopoietic Stem Cells

2y ago
youtube.com

Scientist Stories: Dana Pe'er, Single-Cell Gene Regulation

2y ago
youtube.com

Scientist Stories: Hans Waterham, The value of phenotypic assays in peroxisomal disorders

2y ago
youtube.com

Scientist Stories: Michael Rosenblum, Exploring Regulatory T-Cells

2y ago
youtube.com

Scientist Stories: Hannah Mitchison, Expanding Ciliopathies

2y ago
youtube.com

Scientist Stories: Leonardo Ferreira, Engineered Immune Cell Therapies

2y ago
youtube.com

Scientist Stories: Joel Zlotogora, Genetic carrier screening programs for reproductive purposes

2y ago
See all content